This will be a good measure of Will Dix's ability to steer and manage stakeholders. It's an opportunity to clearly differentiate himself from the progenitor company.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025